|
covid-19 |
23 |
|
mental health |
10 |
|
myocardial infarction |
10 |
|
stroke |
8 |
|
atrial fibrillation |
7 |
|
family well-being |
7 |
|
health literacy |
7 |
|
information sharing |
7 |
|
intubation |
7 |
|
mortality |
7 |
|
preventive measures |
7 |
|
all-cause mortality |
6 |
|
angiotensin receptor blockers |
6 |
|
angiotensinconverting enzyme inhibitors |
6 |
|
anxiety |
6 |
|
cancer |
6 |
|
cardiovascular mortality |
6 |
|
child maltreatment |
6 |
|
covid-19 incidence |
6 |
|
depression symptom |
6 |
|
diabetes |
6 |
|
diabetes mellitus |
6 |
|
dipeptidyl peptidase-4 inhibitors |
6 |
|
heart failure |
6 |
|
hong kong |
6 |
|
income instability |
6 |
|
intensive care unit |
6 |
|
job loss |
6 |
|
parenting |
6 |
|
sodium-glucose co-transporter |
6 |
|
sodium-glucose cotransporter-2 inhibitors |
6 |
|
stress |
6 |
|
vulnerable group |
6 |
|
confirmatory factor analysis |
5 |
|
medical education |
5 |
|
myocarditis |
5 |
|
myopericarditis |
5 |
|
online interprofessional education |
5 |
|
pericarditis |
5 |
|
vaccine |
5 |
|
validation |
5 |
|
warfarin |
5 |
|
big data |
4 |
|
blood pressure variability |
4 |
|
crew resource management |
4 |
|
deliberate self-harm |
4 |
|
dipeptidyl peptidase-4 inhibitors, diabetes mellitus |
4 |
|
edoxaban |
4 |
|
electrocardiography |
4 |
|
emergency department |
4 |
|
fracture |
4 |
|
metformin |
4 |
|
neutrophil-to-lymphocyte ratio |
4 |
|
osteoporotic |
4 |
|
predictive model |
4 |
|
risk score |
4 |
|
risk stratification, dementia |
4 |
|
safety |
4 |
|
sars-cov-2 |
4 |
|
self-harm |
4 |
|
self-injury |
4 |
|
self-violence |
4 |
|
simulation |
4 |
|
sulphonylurea |
4 |
|
syncope |
4 |
|
teamwork |
4 |
|
unprotected left |
4 |
|
alzheimer's disease |
3 |
|
cognitive dysfunction |
3 |
|
covid-19 pandemic |
3 |
|
curfew |
3 |
|
dementia |
3 |
|
dpp4 |
3 |
|
dpp4 inhibitor |
3 |
|
electronic health records |
3 |
|
lockdown |
3 |
|
national containment |
3 |
|
operations management |
3 |
|
parkinson's disease |
3 |
|
patient boarding |
3 |
|
sglt2 |
3 |
|
sglt2 (sodium-glucose cotransporter 2) inhibitor |
3 |
|
socio-demographic characteristics |
3 |
|
spatial analysis |
3 |
|
stay-at-home |
3 |
|
time series analysis |
3 |
|
urban geometry |
3 |
|
admissions |
2 |
|
ambulances |
2 |
|
attendances |
2 |
|
brugada syndrome |
2 |
|
cardiopulmonary resuscitation |
2 |
|
cardiovascular disease |
2 |
|
cardiovascular health |
2 |
|
case mix |
2 |
|
chinese |
2 |
|
demand |
2 |
|
emergency departments |
2 |
|
emergency medical services |
2 |
|
gender difference |
2 |
|
glasgow coma scale |
2 |
|
heart arrest |
2 |
|
pharyngeal |
2 |
|
professional education |
2 |
|
reflex |
2 |
|
resources |
2 |
|
risk stratification |
2 |
|
social determinants of health |
2 |
|
sudden cardiac death |
2 |
|
unconsciousness |
2 |
|
undergraduate medical education |
2 |
|
ventricular fibrillation |
2 |
|
anticoagulation |
1 |
|
barium carbonate |
1 |
|
continuous venovenous hemodiafiltration |
1 |
|
emergency medicine |
1 |
|
endocarditis |
1 |
|
followership |
1 |
|
gastric lavage |
1 |
|
hypokalemia |
1 |
|
laryngoscopy |
1 |
|
leadership development |
1 |
|
medical school |
1 |
|
medical students |
1 |
|
ramped position |
1 |
|
sodium thiosulfate |
1 |
|
supine position |
1 |
|
team building |
1 |
|
thromboembolism |
1 |
|
thrombosis |
1 |
|
tracheal |
1 |
|
undergraduate training |
1 |
|
whole bowel irrigation |
1 |
